# Automated Screen for Fetal Aneuploidy

> **NCT03635359** · — · UNKNOWN · sponsor: **BioCeryx** · enrollment: 2000 (estimated)

## Conditions studied

- Trisomy 21 and Other Fetal Aneuploidy

## Interventions

- **DIAGNOSTIC_TEST:** blood test

## Key facts

- **NCT ID:** NCT03635359
- **Lead sponsor:** BioCeryx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-15
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-06-30
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2018-08-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03635359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03635359, "Automated Screen for Fetal Aneuploidy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03635359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*